Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > reinstate the uptick rule. Please share the link.
View:
Post by winr88 on Feb 24, 2021 8:44am

reinstate the uptick rule. Please share the link.

reinstate the uptick rule.

 Who as a buying stockholder would be selling so heavily when such good news arrived? How many US cities have trial sites and what is occuring Maybe, since it is so easy to short a stock that the short sellers who by the way OWN NO SHARES were able to borrow them, and sell them short for a profit. On whose dime was that? Ours we had to invest our hard earned dollars so there is liquidity for them to borrow our shares short and take that money out as profit to them and at our expense? What did they buy, what responsibility do they have to shareholders? NONE. From my standpoint they are stealing our money easily without impunity and with the uptick rule that would be limited.

Known as Rule 10(a)(1) of the Securities Exchange Act of 1934, the uptick rule allows investors to short a security only at a price higher than the security's last trade.
The uptick rule states that you cannot sell a stock short on a down tick. You must wait until the price of the stock you are looking to sell short has an uptick before you can enter your trade. In theory, this rule is supposed to reduce dramatic bear runs on stocks that are fueled by short sellers.



Uptick Rule

was originally created by the Securities and Exchange Commission (SEC) in 1938 to prevent short sellers from conducting bear raids on companies whose stock prices were falling lower and lower and lower. Sixty-nine years later, at the end of 2007, the SEC dropped the uptick rule. However, there are rumblings on Wall Street and in Washington that the uptick rule might be brought back.

[VIDEO] Understanding the Uptick Rule

Video Player
00:00
 
00:00

Bringing the Uptick Rule Back

During the financial sector meltdown on Wall Street in 2008, the SEC temporarily banned short selling on financial stocks like Citigroup (C), JPMorgan Chase (JPM) and Wells Fargo (WFC) in an attempt to help stabilize their stock prices.

This measure seemed to slow the decent of these stocks, but in the long run, many financial stocks continued to drop to just above penny status.

Even so, in a recent testimony before the House Financial Services, Fed Chairman Ben Bernanke said reinstating the uptick rule across all stocks, not just financial stocks, “might have had some benefit” on stock values during the market collapse.

If the SEC does, in fact, reinstate the uptick rule, watch for stock prices to stabilize somewhat in the short term.

At the very least follow this link and sign the petition to urge govrnment and Securities commission the reinstate the uptick rule
You can also white your MP and perhaps as I am inquiring with my broker if I can limit my shares from being borrowed for short selling.

https://signup.savecanadianmining.com/
Comment by blackjack0 on Feb 24, 2021 9:00am
Fully agree! This is an issue that needs to be addressed. I have been in contact with my MLA. Who assured me that this is being looked at. But looking at isn't good enough.they need to end this ridiculous policy and reinstate the uptick rule. Contacting your MLA would be a good start 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250